Literature DB >> 15999958

Intensive glycemic management in critically ill patients.

James Krinsley1, Brian Grissler.   

Abstract

BACKGROUND: The effect of an intensive glycemic management protocol was assessed in a heterogeneous population of critically ill adult patients.
METHODS: Patients representing 800 consecutive admissions following the institution of the protocol were compared with the 800 admissions immediately preceding the institution of the protocol in a 14-bed mixed medical-surgical intensive care unit (ICU). The protocol used intensive monitoring and treatment to maintain blood glucose values >140 mg/dl. Continuous intravenous insulin was used if glucose values were >200 mg/dl on two successive occasions.
RESULTS: Mean glucose decreased from 152.3 mg/dl to 130.7 mg/dl (p < .001), marked by a 56.3% reduction in the percentage of glucose values > or =200 mg/dl, without a significant change in hypoglycemia. There were decreases in the development of new renal insufficiency (p = .034) and in the number of patients receiving transfusion of packed red blood cells (p = .035) during the protocol period. Hospital mortality decreased 29.3% (p = .002), and ICU length of stay decreased 10.8% (p = .011) after institution of the protocol. DISCUSSION: The 29.3% relative reduction in hospital mortality seen among the treatment patients following institution of the protocol probably exceeded the expectations of the initiative's champions. The culture of the ICU regarding glycemic control changed definitively. The protocol was extended to an intermediate care unit, resulting in improvement in glycemic control without an increase in hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999958     DOI: 10.1016/s1553-7250(05)31039-7

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  5 in total

1.  Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  E H Baker; C H Janaway; B J Philips; A L Brennan; D L Baines; D M Wood; P W Jones
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

2.  Continuous perioperative insulin infusion therapy for patients with type 2 diabetes undergoing bariatric surgery.

Authors:  R Blackstone; J Kieran; M Davis; L Rivera
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

3.  Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine.

Authors:  Marcus J Schultz; Annick A N M Royakkers; Marcel Levi; Hazra S Moeniralam; Peter E Spronk
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

4.  Safety of intravenous insulin aspart compared to regular human insulin in patients undergoing ICU monitoring post cardiac surgery: an Indian experience.

Authors:  Manoj Chawla; Harshad Malve; Harshvi Shah; Shwetal Shinde; Anil Bhoraskar
Journal:  J Diabetes Metab Disord       Date:  2015-04-03

Review 5.  A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset.

Authors:  Saeid Eslami; Nicolette F de Keizer; Evert de Jonge; Marcus J Schultz; Ameen Abu-Hanna
Journal:  Crit Care       Date:  2008-11-11       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.